Universal Beteiligungs und Servicegesellschaft mbH Sells 52,287 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 52.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 47,315 shares of the company's stock after selling 52,287 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.10% of Prestige Consumer Healthcare worth $4,068,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Cerity Partners LLC increased its holdings in Prestige Consumer Healthcare by 3.7% in the 1st quarter. Cerity Partners LLC now owns 3,666 shares of the company's stock valued at $315,000 after acquiring an additional 132 shares during the last quarter. Franklin Resources Inc. increased its holdings in Prestige Consumer Healthcare by 0.7% in the 4th quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after acquiring an additional 150 shares during the last quarter. KBC Group NV increased its holdings in Prestige Consumer Healthcare by 7.4% in the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after acquiring an additional 151 shares during the last quarter. CIBC Private Wealth Group LLC increased its holdings in Prestige Consumer Healthcare by 48.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after acquiring an additional 152 shares during the last quarter. Finally, McIlrath & Eck LLC increased its holdings in Prestige Consumer Healthcare by 19.1% in the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after acquiring an additional 154 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Price Performance

Shares of NYSE:PBH traded down $0.39 on Friday, reaching $73.56. The company's stock had a trading volume of 130,674 shares, compared to its average volume of 365,750. Prestige Consumer Healthcare Inc. has a 52-week low of $64.94 and a 52-week high of $90.04. The company has a market cap of $3.64 billion, a P/E ratio of 17.13, a PEG ratio of 2.25 and a beta of 0.43. The company has a 50-day simple moving average of $80.89 and a 200 day simple moving average of $82.28. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The firm had revenue of $296.52 million during the quarter, compared to analysts' expectations of $289.36 million. During the same period in the previous year, the company earned $1.02 EPS. The firm's revenue for the quarter was up 7.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.